A moderate transfusion regimen may reduce iron loading in β-thalassemia major without producing excessive expansion of erythropoiesis

Transfusion

Volumn 37, Issue 2, 1997, Pages 135-140

  Cazzola, M ^a   Borgna Pignatti, C ^b   Locatelli, F ^a   Ponchio, L ^a   Beguin, Y ^c   De Stefano, P ^d  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; TRANSFERRIN RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; FEMALE; GROWTH RETARDATION; HEMOGLOBIN DETERMINATION; HUMAN; IRON OVERLOAD; MALE; THALASSEMIA MAJOR;

EID: 0031041962     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37297203514.x     Document Type: Article

References (18)

1. Napier JA. Blood transfusion therapy: a problem-oriented approach. Chichester, UK: Wiley, 1987.
2. Piomelli S, Karpatkin MH, Arzanian M, et al. Hypertransfusion regimen in patients with Cooley's anemia. Ann N Y Acad Sci 1974;232:186-92.
3. Propper RD, Button LN, Nathan DG. New approaches to the transfusion management of thalassemia. Blood 1980;55:55-60.
4. Beguin Y, Clemons GK, Pootrakul P, Fillet G. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 1993;81:1067-76.
5. Rebulla P, Modell B. Transfusion requirements and effects in patients with thalassaemia major. Colleycare Programme. Lancet 1991;337:277-80.
6. Brittenham GM, Griffith PM, Nienhuis AW, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994;331:567-73.
7. Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med 1994;331:574-8.
8. Piomelli S. The management of patients with Cooley's anemia: transfusions and splenectomy. Semin Hematol 1995;32:262-8.
9. Pippard MJ, Callender ST, Warner GT, Weatherall DJ. Iron absorption and loading in β-thalassaemia intermedia. Lancet 1979;2:819-21.
10. Pootrakul P, Kitcharoen K, Yansukon P, et al. The effect of erythroid hyperplasia on iron balance. Blood 1988;71:1124-9.
11. Pootrakul P, Hungsprenges S, Fucharoen S, et al. Relation between erythropoiesis and bone metabolism in thalassemia. N Engl J Med 1981;304:1470-3.
12. Pippard MJ, Rajagopalan B, Callender ST, Weatherall DJ. Iron loading, chronic anemia, and erythroid hyperplasia as determinants of the clinical features of β-thalassemia intermedia. In: Weatherall DJ, Fiorelli G, Gorini S, eds. Advances in red blood cell biology. New York: Raven Press, 1982:63-70.
13. Camaschella C, Cappellini MD. Thalassemia intermedia. Haematologica 1995;80:58-68.
14. Cazzola M, De Stefano P, Ponchio L, et al. Relationship between transfusion regimen and suppression of erythropoiesis in β-thalassemia major. Br J Hematol 1995:89:471-8.
15. Cazzola M, Pootrakul P, Bergamaschi G, et al. Adequacy of iron supply for erythropoiesis: in vivo observations in humans. J Lab Clin Med 1987;110:734-9.
16. Pippard MJ, Callender ST, Finch CA. Ferrioxamine excretion in iron-loaded man. Blood 1982;60:288-94.
17. Cazzola M, Ascari E, Barosi G, et al. Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet 1983;65:149-54.
18. Bronspiegel-Weintrob N, Olivieri NF, Tyler B, et al. Effect of age at the start of iron chelation therapy on gonadal function in β-thalassemia major. N Engl J Med 1990;323:713-9.